We serve Chemical Name:3,5-Dimethylisoxazole-4-boronic acid CAS:16114-47-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3,5-Dimethylisoxazole-4-boronic acid
CAS.NO:16114-47-9
Synonyms:Boronic acid, B-(3,5-dimethyl-4-isoxazolyl)-;MFCD02677945;(3,5-Dimethyl-1,2-oxazol-4-yl)boronic acid;3,5-Dimethylisoxazol-4-yl-4-boronic acid;(3,5-Dimethylisoxazol-4-yl)boronic acid;3,5-Dimethylisoxazole-4-Boronic Acid;(3,5-Dimethyl-4-isoxazolyl)-boronic acid
Molecular Formula:C5H8BNO3
Molecular Weight:140.933
HS Code:2934999090
Physical and Chemical Properties:
Melting point:108-113 °C
Boiling point:334.0±52.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.486
PSA:66.49000
Exact Mass:141.059723
LogP:0.37
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like Boronic acid, B-(3,5-dimethyl-4-isoxazolyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3,5-Dimethyl-4-isoxazolyl)-boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Boronic acid, B-(3,5-dimethyl-4-isoxazolyl)- Use and application,(3,5-Dimethyl-4-isoxazolyl)-boronic acid technical grade,usp/ep/jp grade.
Related News: Recipharm joined the COVID-19 fight in December, signing on to produce the Moderna vaccine at its plant in Monts, France. The company hasn’t revealed if the new facilities will be engaged in COVID-19 vaccine production, though the plant in Morocco will “mirror” a new fill-finish line it added in France. (S)-8-methyl-1,4-dipropyl-1,4,7,8-tetrahydro-5H-imidazo[2,1-i]purin-5-one manufacturers Earlier this year, the US Food and Drug Administration approved Verquvo to reduce the risk of cardiovascular death and heart failure hospitalisation, following a hospitalisation for heart failure or need for outpatients intravenous (IV) diuretics in adults with symptomatic chronic heart failure and ejection fraction less than 45%. (6-chloro-4-cyclopentyloxy-2-methyl-pyridin-3-yl)-methanol suppliers “The approval of Verquvo in the EU will provide doctors, health care professionals and patients with an important treatment option to complement currently available heart failure therapies,” he added. 2-amino-3-pyridin-3-ylpentanedioic acid vendor & factory “The approval of Verquvo in the EU will provide doctors, health care professionals and patients with an important treatment option to complement currently available heart failure therapies,” he added.,So-called “off” periods occur when a Parkinson’s patient has difficulty moving about and occur when the effect of the last dose of another common Parkinson’s drug, known as levodopa, wears off.
